The expression of cytoglobin as a prognostic factor in gliomas: a retrospective analysis of 88 patients
By: Xu, Hong-Wu, Huang, Yue-Jun, Xie, Ze-Yu, Lin, Lan, Guo, Yan-Chun, Zhuang, Ze-Rui, Lin, Xin-Peng, Zhou, Wen, Li, Mu, Huang, Hai-Hua, Wei, Xiao-Long, Man, Kwan, Zhang, Guo-Jun

BioMed Central Ltd
2013-05-20; doi: 10.1186/1471-2407-13-247
Abstract

Background

Evidence suggests that cytoglobin (Cygb) may function as a tumor suppressor gene.

Methods

We immunohistochemically evaluated the expression of Cygb, phosphatidylinositol-3 kinase (PI-3K), phosphorylated (p)-Akt, Interleukin-6 (IL-6), tumor necrosis factor-alpha (TNFalpha) and vascular endothelial growth factor (VEGF) in 88 patients with 41 high-grade gliomas and 47 low-grade gliomas. Intratumoral microvessel density (IMD) was also determined and associated with clinicopathological factors.

Results

Low expression of Cygb was significantly associated with the higher histological grading and tumor recurrence. A significant negative correlation emerged between Cygb expression and PI3K, p-Akt, IL-6, TNFalpha or VEGF expression. Cygb expression was negatively correlated with IMD. There was a positive correlation between PI3K, p-Akt, IL-6, TNFalpha and VEGF expression with IMD.High histologic grade, tumor recurrence, decreased Cygb expression, increased PI3K expression, increased p-Akt expression and increased VEGF expression correlated with patients' overall survival in univariate analysis. However, only histological grading and Cygb expression exhibited a relationship with survival of patients as independent prognostic factors of glioma by multivariate analysis.

Conclusions

Cygb loss may contribute to tumor recurrence and a worse prognosis in gliomas. Cygb may serve as an independent predictive factor for prognosis of glioma patients.




The complete article is available as a provisional PDF. The fully formatted PDF and HTML versions are in production.






Copyright 2026 InterMDnet | Privacy Policy | Disclaimer | System Requirements